ArticleACS omega2026

Computational and Experimental Verification of Cabozantinib Targeting DDX11 to Inhibit DNA Damage Repair in Liver Cancer.

Lianhai Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.